Thomas Delong

10PUBLICATIONS
19CO-AUTHORS
AutoimmunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Haematological tumoursMedical biochemistry - proteins and peptides (incl. medical proteomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Oct 20, 2026
Hybrid Insulin Peptides in Type 1 Diabetes: How They Form and Why They Matter.

|Oct 21, 2025
Strategic Reduction of Hybrid Insulin Peptide Formation Significantly Delays Diabetes Onset in NOD Mice.

Jason Groegler, Kaitlin Mangold, Kelli Nicholson

|Jan 17, 2025
Novel T-Cell Reactivities to Hybrid Insulin Peptides in Islet Autoantibody-Positive At-Risk Individuals.

Anita C Hohenstein, Joylynn B Gallegos, Mylinh Dang

|May 29, 2024
The insulin secretory granule is a hotspot for autoantigen formation in type 1 diabetes.

Jason Groegler, Aïsha Callebaut, Eddie A James

|Aug 30, 2022
Cathepsin D Drives the Formation of Hybrid Insulin Peptides Relevant to the Pathogenesis of Type 1 Diabetes.

Samantha A Crawford, Timothy A Wiles, Janet M Wenzlau

|Sep 14, 2020
Peptide-Spectrum Match Validation with Internal Standards (P-VIS): Internally-Controlled Validation of Mass Spectrometry-Based Peptide Identifications.

Timothy Aaron Wiles, Laura M Saba, Thomas Delong

Pageof 2

Frequent Collaborators

6 joint publications

Kathryn Haskins

3 joint publications

Timothy Aaron Wiles

3 joint publications

Rocky L Baker

2 joint publications

Eddie A James